Published in Metabolism on March 01, 1988
Sex dimorphism and depot differences in adipose tissue function. Biochim Biophys Acta (2013) 1.10
Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women. Metabolism (2008) 1.00
Correlation of biochemical markers and clinical signs of hyperandrogenism in women with polycystic ovary syndrome (PCOS) and women with non-classic congenital adrenal hyperplasia (NCAH). Iran J Reprod Med (2012) 0.75
The relationships between testosterone, body composition, and insulin resistance: a lesson from a case of extreme hyperandrogenism. Diabetes Care (2005) 0.75
Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest (1989) 2.25
99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives. Eur J Nucl Med (2000) 1.83
Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab (1987) 1.78
Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results. Obes Res (2000) 1.56
Cubilin and megalin in radiation-induced renal injury with labelled somatostatin analogues: are we just dealing with the kidney? Eur J Nucl Med Mol Imaging (2005) 1.44
Endocrine ophthalmopathy in a patient under continuous immunosuppressive therapy after cardiac transplantation. Thyroid (1995) 1.43
Immunological risks of IVF. Lancet (1990) 1.42
Technetium-99m human immunoglobulin scintigraphy in psoriatic arthropathy: first results. Eur J Nucl Med (1994) 1.41
Sympathetic modulation of lipolysis in subcutaneous adipose tissue: effects of gender and energy restriction. J Lab Clin Med (1999) 1.40
The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res (1974) 1.28
Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int J Pancreatol (1992) 1.26
Does fall in tissue glucose precede fall in blood glucose? Diabetologia (1996) 1.26
Differentiation of adipocyte precursor cells from obese and nonobese adult women and from different adipose tissue sites. Horm Metab Res Suppl (1988) 1.19
Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man. Horm Metab Res (1976) 1.14
Hypergastrinemia induced by glucocorticoid and corticotropin treatment in man. Am J Dig Dis (1976) 1.09
Action of streptozotocin on insulin and glucagon responses of rat islets. Horm Metab Res (1970) 1.06
Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med (1997) 1.06
Effects of somatostatin on gastric secretion and gastrin release in man. Digestion (1975) 1.05
Gastrin concentration in plasma of the neonate at birth and after the first feeding. Pediatrics (1976) 1.04
[Direct stimulation of insulin secretion in vitro by scretion]. Dtsch Med Wochenschr (1965) 1.03
Action of B-hydroxy butyrate, acetoacetate and palmitate on the insulin release in the perfused isolated rat pancreas. Horm Metab Res (1974) 1.00
Effect of bombesin upon plasma somatostatin-like immunoreactivity, insulin and glucagon in normal and chemically sympathectomized dogs. Regul Pept (1980) 0.98
[Resynthesis of insulin from the preoxidized A chain and reduced B chain]. Justus Liebigs Ann Chem (1966) 0.97
Subcutaneous glucose concentration in humans. Real estimation and continuous monitoring. Diabetes Care (1995) 0.97
Differential and integral corticosteroid feedback effects on ACTH secretion in hypoadrenocorticism. J Clin Invest (1979) 0.95
Acute hypothyroidism slows the rate of left ventricular diastolic relaxation. Can J Physiol Pharmacol (1989) 0.94
Paradoxical ACTH response to glucocorticoids in Cushing's disease. N Engl J Med (1977) 0.92
Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes. Ann Nutr Metab (1988) 0.92
Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas. Horm Metab Res (1971) 0.91
Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer. J Med Genet (2004) 0.90
Effects of splanchnic nerve stimulation on the adrenal cortex may be mediated by chromaffin cells in a paracrine manner. Endocrinology (1990) 0.90
Mania caused by a diencephalic lesion. Neuropsychologia (2002) 0.89
[Metabolic changes in zero-diet]. Internist (Berl) (1970) 0.89
Stimulation of H-3-leucine incorporation into the proinsulin and insulin fraction of isolated pancreatic mouse islets in the presence of glucagon, theophylline and cyclic AMP. Diabetes (1973) 0.89
[The endocrine pancreas. From the isolated islet to the "artificial pancreas" (author's transl)]. MMW Munch Med Wochenschr (1976) 0.89
18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective. Exp Gerontol (2003) 0.88
Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid (1997) 0.88
On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis. Diabetologia (1992) 0.88
[Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study]. Klin Wochenschr (1989) 0.88
Insulin therapy in relation to circulating C-peptide levels. Diabetes (1978) 0.88
The effect of serotonin on in vitro insulin secretion and biosynthesis in mice. Diabetologia (1974) 0.87
Somatostatin: a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency. Klin Wochenschr (1976) 0.87
Effects of moderate consumption of white wine on weight loss in overweight and obese subjects. Int J Obes Relat Metab Disord (2004) 0.87
Role of the vasoactive intestinal peptide in a neuroendocrine regulation of the adrenal cortex. Neuroendocrinology (1991) 0.86
The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human sub-cutaneous tissue and plasma. Biosens Bioelectron (1993) 0.85
Biosynthetic human insulin: progress and prospects. Diabetes Care (1981) 0.85
Inhibition of cholecystokinin-pancreozymin release by somatostatin. Lancet (1977) 0.85
Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer. Q J Nucl Med Mol Imaging (2004) 0.85
Dilatory and inotropic effects of corticotropin-releasing factor (CRF) on the isolated heart. Effects on atrial natriuretic peptide (ANP) release. Horm Metab Res (1992) 0.85
Inhibition of TSH-stimulated radioiodine turnover and release of T4 and T3 in vivo by somatostatin. Metabolism (1978) 0.85
On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future. XII Congress of the International Diabetes Federation, Madrid, 22-28 September 1985. Diabetologia (1987) 0.84
Binding and biological actions of insulin-like growth factors on human arterial smooth muscle cells. Horm Metab Res (1982) 0.83
beta 1-Integrin expression in papillary thyroid carcinoma. Anticancer Res (1998) 0.83
(Pro-) insulin biosynthesis and release of newly synthesized (pro-) insulin from isolated islets of rat pancreas in the presence of amino acids and sulphonylureas. Eur J Clin Invest (1975) 0.83
Effects of neurotransmitters on the release of corticotropin releasing hormone (CRH) by rat hypothalamic tissue in vitro. Exp Brain Res (1980) 0.83
Organ-specific antibodies against ovary in patients with systemic lupus erythematosus. Am J Obstet Gynecol (1989) 0.83
Does insulin play a role in the regulation of its own secretion? Horm Metab Res (1978) 0.83
Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring. Diabetes Care (1985) 0.83
Evidence for the presence of human chorionic gonadotropin (hCG) and free beta-subunit of hCG in the human pituitary. J Clin Endocrinol Metab (1990) 0.83
Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum. J Clin Invest (1989) 0.83
The influence of circulating thyroxine serum concentration on hepatic thyroxine deiodinating activity in rats. Exp Clin Endocrinol (1990) 0.83
[On the regulation of nonesterified fatty acids with special reference to prostaglandins]. Dtsch Med Wochenschr (1966) 0.83
Studies on juvenile--type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides. Diabete Metab (1975) 0.83
Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell. Horm Metab Res (1976) 0.82
Effects of synthetic rat C-peptide in normal and diabetic rats. Diabetologia (1983) 0.82
Isolation of IgG islet cell autoantibody-producing B lymphocytes from the peripheral blood of type 1 diabetic patients and an ICA-positive non-diabetic individual. Horm Metab Res (1989) 0.82
Hyperglucagonemia of the isolated perfused pancreas of diabetic mice (db-db). Diabetologia (1973) 0.82
Primary secretion of insulin and secondary release of glucagon from the isolated perfused rat pancreas following stimulation with pancreozymin. Horm Metab Res (1969) 0.82
Combination of microdialysis and glucosensor permits continuous (on line) SC glucose monitoring in a patient operated device. II. Evaluation in animals. Horm Metab Res (1992) 0.82
Thallium-201 gated single-photon emission tomography for the assessment of left ventricular ejection fraction and regional wall motion abnormalities in comparison with two-dimensional echocardiography. Eur J Nucl Med (1999) 0.82
Growth hormone radiologand assay unresponsive to human prolactin. J Clin Endocrinol Metab (1976) 0.81
Long-term experiences with a computerized diabetes management and glucose monitoring system in insulin-dependent diabetic patients. Diabetes Res Clin Pract (1994) 0.81
Histometric investigations on the testicular tissue of rats with alloxan diabetes and Chinese hamsters with spontaneous diabetes. Acta Endocrinol (Copenh) (1967) 0.81
Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system. Diabetes Care (1981) 0.81
Problems and artefacts in ACTH assay. Horm Metab Res (1972) 0.81
Vascular endothelial growth factor in serum and in the follicular fluid of patients undergoing hormonal stimulation for in-vitro fertilization. Hum Reprod (1998) 0.81
Somatostatin modulation of pancreatic glucagon, insulin, glucose and free fatty acids following beta-adrenergic stimulation. J Clin Endocrinol Metab (1977) 0.81
Spontaneous and stimulated secretion of QUSO-extractable immunoassayable ACTH in man. Klin Wochenschr (1974) 0.81
Effect of beta-casomorphins and analogs on insulin release in dogs. Endocrinology (1983) 0.80
Left ventricular function at rest and during exercise in acute hypothyroidism. Br Heart J (1988) 0.80
Inhibition of frusemide-induced hyperreninaemia by growth-hormone release-inhibiting hormone in man. Lancet (1976) 0.80
Do we need 18F-FDG-positron emission tomography as a functional imaging technique for diagnosing large vessel arteritis? Clin Exp Rheumatol (2004) 0.80
Estimation of cholecystokinin-pancreozymin (CCK) in human plasma and tissue by a specific radioimmunoassay and the immunohistochemical identification of pancreozymin-producing cells in the duodenum of humans. Clin Chim Acta (1977) 0.80
Intravenous glucose tolerance and insulin secretion in the rat after thyroidectomy. Horm Metab Res (1972) 0.80
Urinary excretion of testosterone and epitestosterone in men, women and children, in health and disease. Clin Chim Acta (1971) 0.80
Release of immunoreactive and radioactively prelabelled endogenous (pro)-insulin from isolated islets of rat pancreas in the presence of exogenous insulin. J Endocrinol (1977) 0.80
Insulin secretion and biosynthesis in sucrose fed rats. Diabetologia (1976) 0.80
Effect of beta-casomorphins on somatostatin release in dogs. Endocrinology (1983) 0.80
Studies on the pathogenesis of the dawn phenomenon in insulin-dependent diabetic patients. Metabolism (1984) 0.80
Modulation of post-prandial insulin release by ingested opiate-like substances in dogs. Diabetologia (1983) 0.79
Serum angiotensin-converting enzyme activity and active renin plasma concentrations in insulin-dependent diabetes mellitus. Diabetes Res Clin Pract (1992) 0.79
[Effect of D-thyroxine-Na (Dynothel) on hypercholesteremia]. Verh Dtsch Ges Inn Med (1974) 0.79
Insulin stimulating action of secretin in maturity onset diabetics. Horm Metab Res (1969) 0.79
Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects. Klin Wochenschr (1983) 0.79
Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects. Diabetes (1985) 0.79
Effect of continuous and oscillatory portal vein insulin infusion upon glucose-induced insulin release in rats. Res Exp Med (Berl) (1984) 0.79